News Daily News POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies L.A. McKeown July 15, 2025
News Daily News Philips Recalls Tack Endovascular Systems and Stops Distribution L.A. McKeown March 03, 2025
News Daily News AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care L.A. McKeown May 17, 2024
News Daily News Surgeons Say ACC/AHA Chronic Coronary Disease Guidelines Whiffed Michael O'Riordan August 03, 2023
News Daily News Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA L.A. McKeown July 11, 2023
News Daily News AHA Scientific Statement Addresses Health Disparities in PAD L.A. McKeown June 23, 2023
News Daily News Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis Michael O'Riordan February 24, 2023
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Daily News Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy L.A. McKeown June 01, 2022
News Daily News Good News and Bad for High-Intensity Statin Use in ASCVD Michael O'Riordan May 05, 2022
News Daily News Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities Michael O'Riordan April 25, 2022
News Daily News Routine IVUS in Peripheral Interventions Supported by Small RCT L.A. McKeown March 09, 2022
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Daily News Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles Michael O'Riordan May 12, 2021
News Daily News Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials L.A. McKeown April 26, 2021
News Daily News Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail L.A. McKeown April 22, 2021
News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020